Literature DB >> 10817547

Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.

P Garnero1, J C Rousseau, P D Delmas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10817547     DOI： 10.1002/1529-0131(200005)43:5<953::AID-ANR1>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  72 in total

1.  Markers of joint destruction: principles, problems, and potential.

Authors:  S A Young-Min; T E Cawston; I D Griffiths
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

Authors:  P Garnero; M Piperno; E Gineyts; S Christgau; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 3.  Validation of new biomarkers in systemic autoimmune diseases.

Authors:  Maria G Tektonidou; Michael M Ward
Journal:  Nat Rev Rheumatol       Date:  2011-11-01       Impact factor: 20.543

4.  Whole blood lead levels are associated with biomarkers of joint tissue metabolism in African American and white men and women: the Johnston County Osteoarthritis Project.

Authors:  Amanda E Nelson; Sanjay Chaudhary; Virginia B Kraus; Fang Fang; Jiu-Chiuan Chen; Todd A Schwartz; Xiaoyan A Shi; Jordan B Renner; Thomas V Stabler; Charles G Helmick; Kathleen Caldwell; A Robin Poole; Joanne M Jordan
Journal:  Environ Res       Date:  2011-08-12       Impact factor: 6.498

5.  Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.

Authors:  O Bruyere; J Collette; M Kothari; S Zaim; D White; H Genant; C Peterfy; N Burlet; D Ethgen; T Montague; C Dabrowski; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

6.  Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.

Authors:  B Mazières; P Garnero; A Guéguen; M Abbal; L Berdah; M Lequesne; M Nguyen; J-P Salles; E Vignon; M Dougados
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

7.  Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency.

Authors:  Nikolaus A Streich; David Zimmermann; Holger Schmitt; Gerrit Bode
Journal:  Int Orthop       Date:  2011-01-11       Impact factor: 3.075

8.  Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.

Authors:  P Garnero; T Conrozier; S Christgau; P Mathieu; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

9.  Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study.

Authors:  I Meulenbelt; M Kloppenburg; H M Kroon; J J Houwing-Duistermaat; P Garnero; M-P Hellio Le Graverand; J Degroot; P E Slagboom
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

10.  Serum hyaluronic acid levels in patients with ankylosing spondylitis.

Authors:  Mehmet Tuncay Duruöz; Yasemin Turan; Lale Cerrahoglu; Banu Isbilen
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.